Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score.
about
Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Introduction of second-generat ...... d outcome study (EUTOS) score.
@en
type
label
Introduction of second-generat ...... d outcome study (EUTOS) score.
@en
prefLabel
Introduction of second-generat ...... d outcome study (EUTOS) score.
@en
P2093
P2860
P1433
P1476
Introduction of second-generat ...... d outcome study (EUTOS) score.
@en
P2093
Eriko Sato
Hiroyuki Fujita
Isao Fujioka
Kei-Ji Sugimoto
Maho Ishikawa
Masahiro Kizaki
Michihide Tokuhira
Norio Asou
Norio Komatsu
Noriyoshi Iriyama
P2860
P356
10.1080/10428194.2017.1365858
P577
2017-08-25T00:00:00Z